Alivus Life Sciences Q4FY24-25: Robust Revenue Growth amid Expansion, Risks Loom
Moneylife Digital Team 22 May 2025
Alivus Life Sciences Ltd (Alivus), previously Glenmark Life Sciences, operates as a developer and manufacturer of active pharmaceutical ingredients (APIs), with a portfolio of 151 molecules...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Free Helpline
Legal Credit
Feedback